TEVA-LOSARTAN/HCTZ (2019-03-06) Mar 6, 2019 · Published by Health Canada · Official notice
Share
Alert type : Drug Recall
Category : Drugs
Issue : Product Safety
Audience : General Public, Healthcare Professionals, Hospitals
Department : Health Canada
Hazard classification : Type I
Lot or serial number Brand name Companies Dosage form DIN, NPN, DIN-HIM Strength 35344801A, 35349397A Teva-Losartan / HCTZ 50/12.5mg Tablet Recalling Firm Teva Canada Ltd. 30 Novopharm Court Toronto M1B 2K9 Ontario CANADA Marketing Authorization Holder Teva Canada Ltd. 30 Novopharm Court Toronto M1B 2K9 Ontario CANADA Tablet DIN 02358263 Hydrochlorothiazide 12.5mg
Recalled Products
Teva-Losartan / HCTZ 50/12.5mg Tablet
Affected lots manufactured with an API that may contain the impurity N-nitroso-N-methyl-4-aminobutyric acid (referred as “NMBA”) above the acceptable level.